David Greenberg, M.D.
Associate Professor

University

Johns Hopkins Bloomberg School of Public Health (1995)

Medical School

Baylor College of Medicine (1999)

Residency

Baylor College of Medicine (2002), Internal Medicine

Residency

Baylor College of Medicine (2003), Internal Medicine

Fellowship

National Institutes of Health (2006), Infectious Diseases

• Infectious Diseases

Immune Deficiencies

Infections

Infectious Diseases

Inflammatory & Infectious Disorders

Respiratory Infectious Diseases

• Acinetobacter baumannii
• Antimicrobial development
• Burkholderia cepacia complex
• Gram-negative Bacterial Infections
• Infections in Immunocompromised Hosts

Featured Publications

Inhibition of Pseudomonas aeruginosa by Peptide-conjugated Phosphorodiamidate Morpholino Oligomers.

Howard JJ, Sturge CR, Moustafa DA, Daly SM, Marshall-Batty KR, Felder CF, Zamora D, Yabe-Gill M, Labandeira-Rey M, Bailey SM, Wong M, Goldberg JB, Geller BL, Greenberg DE Antimicrob. Agents Chemother. 2017 Jan

Peptide-conjugated phosphorodiamidate morpholino oligomer (PPMO) restores carbapenem susceptibility to NDM-1-positive pathogens in vitro and in vivo.

Sully EK, Geller BL, Li L, Moody CM, Bailey SM, Moore AL, Wong M, Nordmann P, Daly SM, Sturge CR, Greenberg DE J. Antimicrob. Chemother. 2016 Dec

Sequence-Specific Targeting of Bacterial Resistance Genes Increases Antibiotic Efficacy.

Ayhan DH, Tamer YT, Akbar M, Bailey SM, Wong M, Daly SM, Greenberg DE, Toprak E PLoS Biol. 2016 Sep 14 9 e1002552

Primary osteomyelitis caused by hypervirulent Klebsiella pneumoniae.

Prokesch BC, TeKippe M, Kim J, Raj P, TeKippe EM, Greenberg DE Lancet Infect Dis 2016 Jul

Antisense phosphorodiamidate morpholino oligomers targeted to an essential gene inhibit Burkholderia cepacia complex

Greenberg DE, Marshall-Batty KR, Brinster LR, Zarember KA, Shaw PA, Mellbye BL, Iversen PL, Holland SM, Geller BL Journal of Infectious Diseases June 2010 201(12) 1822-30

Antisense phosphorodiamidate morpholino oligomers targeted to an essential gene inhibit Burkholderia cepacia complex.

Greenberg DE, Marshall-Batty KR, Brinster LR, Zarember KA, Shaw PA, Mellbye BL, Iversen PL, Holland SM, Geller BL J. Infect. Dis. 2010 Jun 201 12 1822-30

Recurrent Burkholderia infection in patients with chronic granulomatous disease: 11-year experience at a large referral center

Greenberg DE, Goldberg JB, Stock F, Murray PR, Holland SM, Lipuma JJ. Clinical Infectious Diseases June 2009 48(11) 1577-9

Genome sequence analysis of the emerging human pathogenic acetic acid bacterium Granulibacter bethesdensis.

Greenberg DE, Porcella SF, Zelazny AM, Virtaneva K, Sturdevant DE, Kupko JJ, Barbian KD, Babar A, Dorward DW, Holland SM J. Bacteriol. 2007 Dec 189 23 8727-36

A novel bacterium associated with lymphadenitis in a patient with chronic granulomatous disease

Greenberg DE, Ding L, Zelazny AM, Stock F, Wong A, Anderson VL, Miller G, Kleiner DE, Tenorio AR, Brinster L, Dorward DW, Murray PR, Holland SM. PLoS Pathogens April 2006 2(4) e28

A novel bacterium associated with lymphadenitis in a patient with chronic granulomatous disease.

Greenberg DE, Ding L, Zelazny AM, Stock F, Wong A, Anderson VL, Miller G, Kleiner DE, Tenorio AR, Brinster L, Dorward DW, Murray PR, Holland SM PLoS Pathog. 2006 Apr 2 4 e28

• Regents' Outstanding Teacher Award
  (2014)
• Southwestern Association of Teachers
  (2014)
• Excellence in Education Award
  (2013)
• Excellence in Education Award UTSW
  (2012)
• Excellence in Education Award UTSW
  (2011)
• National Institutes of Health
  Director’s Award (2007)
• National Institutes of Health
  Fellows Award for Research Excellence (2006)

• American Society for Microbiology
• Infectious Diseases Society of America
• Society for Leukocyte Biology